Sysmex Europe
Menu

Liquid Biopsy Impact: Zooming in on cancer through ctDNA lens - Welcome!

Welcome to the inaugural post of "Liquid Biopsy Impact," a series dedicated to exploring the evolving landscape of liquid biopsy and its transformative potential in oncology. This series aims to equip you, with the latest advancements and clinical utilities of liquid biopsy, specifically focusing on circulating tumour DNA (ctDNA) analysis. 

Why should you follow this series? 

As experts navigating the intricacies of cancer diagnosis and treatment, staying up to date on new diagnostic technologies, like liquid biopsy, can be difficult. This series delves into the clinical applications of ctDNA analysis, showcasing its potential to: enhance treatment personalization, monitor treatment efficacy, and revolutionize disease monitoring.  

How? Let’s learn from our experts in the video below: 

Building expertise together

Throughout this series, we'll explore the following aspects: 

  • Real-world applications: We'll present routine clinical scenarios where liquid biopsy has significant value, so you can have a clear, concrete examples of its practical impact. 

  • In-depth analysis of ctDNA applications: We'll take a look into the scientific basis and technical aspects of ctDNA analysis to provide you with a comprehensive understanding of its capabilities. 

  • Expert interviews: You’ll gain valuable insights from leading figures in the field through exclusive interviews that discuss the current state and future projections of liquid biopsy. 

  • Health economic considerations: You can explore how cost-effective liquid biopsy is compared to traditional methods, highlighting its potential to optimise healthcare resource allocation. 

Enriching your knowledge base: 

To further enhance your learning experience, we'll incorporate: educational videos, links to relevant webinars, white papers, and peer-reviewed publications for deeper exploration. 

Stay tuned for the next post, where we'll dive deeper into the clinical applications of ctDNA analysis in oncology. 

Welcome aboard! 

Copyright © Sysmex Europe SE. All rights reserved.